Australia Markets open in 4 hrs 19 mins

Why Macquarie and these ASX shares just hit 52-week highs or better

James Mickleboro
boy standing on ladder against the backdrop of a cloudy sky

The market may have been struggling a little this week, but that hasn’t stopped some shares from shooting higher.

Three shares that have just hit 52-week highs or better this week are listed below. Here’s why they are on fire:

The Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) share price continued its ascent and hit an all-time high of $18.57 on Wednesday. Investors have been fighting to get hold of the sleep treatment focused medical device company’s shares following a recent upgrade to its full year guidance. Thanks partly to the release of its new Vitera device, management lifted its guidance to revenue of NZ$1.19 billion and net profit after tax in the range of approximately NZ$255 million to NZ$265 million. The latter compares to net profit after tax of NZ$209.2 million in FY 2019.

The Macquarie Group Ltd (ASX: MQG) share price climbed to a record-high of $138.07 yesterday before edging lower. A strong performance in FY 2019 and a positive medium term outlook appear to be behind its strong share price rise. Its shares were also given a boost by a broker note out of Morgan Stanley this month. According to the note, its analysts have retained their overweight rating and $143.00 price target on the investment bank’s shares. They believe Macquarie will either meet or beat its full year guidance. Another attraction for investors is no doubt its generous dividend yield in a low interest rate environment. Its shares currently offer a partially franked forward 4.3% dividend yield.

The Novita Healthcare Ltd (ASX: NHL) share price raced to a multi-year high of 10 cents on Wednesday. The early childhood technology company’s shares are now up over 900% in the space of just one month. The catalyst for this strong gain was news relating to both its TALi Detect and TALi Train programs. TALi Detect is a digital game-based screening tool to assess potential attention deficits. Whereas TALi Train is an intensive digital program that strengthens children’s three core attention skills. Both programs have recently received determinations that they can be delivered via the U.S. Reimbursement Code system. Management notes that there is a massive market opportunity in the United States.

The post Why Macquarie and these ASX shares just hit 52-week highs or better appeared first on Motley Fool Australia.

If you missed these gains don't worry. Because at their current prices, I suspect that these top shares have plenty of room to run higher in 2020.

NEW. Five Cheap and Good Stocks to Buy in 2020….

Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.


More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019